REQUEST A DEMO
Total
USD $0.00
Search more companies

Souvin Pharmaceuticals (India) Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Souvin Pharmaceuticals (India) Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Souvin Pharmaceuticals (india) Private Limited is an unlisted company, incorporated on 26/05/2009. It has its registered office in the State of PN, India. Company's corporate identification number (CIN) is U24230PN2009PTC134023 and registration number is 134023. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Office No.303, 3Rd Floor, Bremen Business Centre, Near City International School, University Road
Pune; Maharashtra; Postal Code: 411007

Contact Details: Purchase the Souvin Pharmaceuticals (India) Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Souvin Pharmaceuticals (India) Private Limited report to view the information.
Registered Capital:
Purchase the Souvin Pharmaceuticals (India) Private Limited report to view the information.
Incorporation Date:
May 26, 2009
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Company Performance
Financial values in the chart are available after Souvin Pharmaceuticals (India) Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
32.75%
Total operating revenue
32.58%
Operating profit (EBIT)
48.46%
EBITDA
20.63%
Net Profit (Loss) for the Period
49.23%
Total assets
103.88%
Total equity
17.66%
Operating Profit Margin (ROS)
0.17%
Net Profit Margin
0.17%
Return on Equity (ROE)
-9.61%
Debt to Equity Ratio
24.38%
Quick Ratio
0.49%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?